Institution
Pharmacoeconomics and Health Outcomes Research Iberia (Spain)
EScompany
Recent research
- Health & MedicineOpen access
Post‑COVID‑19 Condition (PCC) is characterized by persistent multisystem symptoms, with fatigue and dyspnea among the most disabling. Specialized pro‑resolving mediators (SPMs) may modulate chronic inflammation, while telerehabilitation has emerged as an accessible therapeutic st...
- BiologyOpen access
The incidence, prevalence and onset of type 1 diabetes (T1D) with diabetic ketoacidosis (DKA) in Spain remain insufficiently characterized, despite multiple regional analyses. This study aims to summarize and critically assess epidemiologic data in Spain, incorporating insights f...